HIGHLIGHTS
- who: Chao Shi from the University of Turin, Italy have published the Article: Real-world clinical treatment outcomes in Chinese non-small cell lung cancer with EGFR exon 20 insertion mutations, in the Journal: (JOURNAL)
- what: The study was approved by the Institutional Ethics Committee of Henan Cancer Hospital affiliated with Zhengzhou University (Approval number 2017407) and obtained the informed consent of all patients. The study evaluated the response of clinical treatments in advanced NSCLC patients with different EGFR ex20ins variant types (near loop and far loop). The authors reported 38 different variants of EGFR . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.